 |
|
|
|
 |
|
|
 Contact |  Print version |  PDF version |  Recommend company
|
Bunsenstraße 1
82152 Martinsried
Germany
|
|
Portrait
U3 Pharma AG is an emerging leader in targeted cancer drug development. The company has produced a pipeline of novel cancer antibodies based on discoveries made by its founder Prof. Axel Ullrich, whose pioneering work has led to the development of oncology blockbusters Herceptin(tm) and Sutent(tm). U3 Pharma applies its translational medicine expertise - pairing deep biological and disease-related knowledge, to drug discovery and development. The two lead antibodies are nearing the clinic as potential therapies for breast, lung and colorectal cancers, among others.
Industrial Sectors
Additional information
U3 Pharma AG
Martinsried, Germany
News
|
|
|
|
|
|
Top
